Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Former architecture student takes part in Archiprix in Moscow
2013-06-24

Jurie Swart in Moscow.
24 June 2013

 

“I am proud that I could honour the UFS’ name,” says Jurie Swart. He participated in the prestigious Archiprix in Moscow in May 2013.

Archiprix is an international competition where the world’s top architecture students are selected. Architecture departments, schools and faculties of 1 500 universities from 78 countries worldwide are invited to enter their top master’s students over two study years.

In 2012, Jurie Swart was honoured as regional winner of the Corobrik Architectural Student of the Year Award and also received an honourable mention in the 2012 International Graduate Architecture Projects.

After several months of careful evaluation by a panel of five experts, his thesis, Borderline – mediated landscape, A water research centre for the University of the Free State, Qwaqwa Campus, was nominated as one of the world’s 25 master’s projects to take part in the Archiprix in Moscow. His thesis was also on display at the Central House of Artists in Moscow for a couple of months.

The judges were Yuri Grigoryan (architect and director of the Moscow-based Project Meganom, as well as director of educational programmes at the Strelka Institute in Moscow); Susan Herrington (professor of architecture and landscape architecture at the University of British Columbia in Vancouver, Canada); Kristin Jarmund (architect and director of the Norwegian-based Kjark, an architectural house); Hubert Klumpner (architect, director of the Venezuela-based Urban-Think Tank, and professor of architecture and urban design at the ETH, Zürich ); and Lesley Lokko (architect, academic and author from the UK).

Jurie Swart was selected as the participants’ favourite. “From the top 25, seven winners were announced, and although I didn’t win, it is still an amazing achievement and I am proud to have honoured the university’s name,” he said.

During his visit to Moscow, he also attended a workshop with the rest of the nominated students. This project, with the theme Railroads, was an exercise to help solve Russia’s transport problems.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept